| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine II, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany
2 Department of Medicine I, St. Josef-Hospital, Ruhr-University, Bochum, Germany
3 Institute of Pathology, University-Hospital Munich-Grosshadern, University of Munich, Munich, Germany
4 Max von Pettenkofer-Institute, University of Munich, Munich, Germany
* To whom correspondence should be addressed. E-mail: stephan.brand{at}med.uni-muenchen.de.
Human cytomegaly virus (HCMV) is a major cause of morbidity and mortality in
immunocompromised individuals. Recently, a novel group of cytokines (IL-28A/B and IL-29,
also termed interferon/IFN-
s) was described. Here, we demonstrate that intestinal epithelial
cell (IEC) lines as well as murine and human colonic tissue express the IFN- receptor
subunits IL-28R and IL-10R2. IL-28A and IL-29 binding to their receptor complex activates
ERK-1/2 and SAPK/JNK MAP kinases, and Akt resulting in increased IL-8 protein
expression. IFN-s also induce phosphorylation of STAT1 and significantly increase the
mRNA expression of SOCS-3 and the antiviral proteins MxA and 2',5'-OAS. These signals
result in an up to 83% reduction of cells positive for HCMV immediate early protein after
HCMV infection. In mice, IL-28A mRNA expression is upregulated following infection with
murine cytomegaly virus (MCMV) in vivo. Both, IL-28A and IL-29 decrease significantly
cell proliferation but have no effect on Fas induced apoptosis. In conclusion, intestinal
epithelial cells express functional receptors for IFN-s, which mediate antiviral and
antiproliferative signals in intestinal epithelial cells suggesting a potential for therapeutic use
in certain viral infections and as (antiproliferative) anti-cancer therapy.
This article has been cited by other articles:
|
|
 |
|
  J Dambacher, F Beigel, K Zitzmann, E N De Toni, B Goke, H M Diepolder, C J Auernhammer, and S Brand The role of the novel Th17 cytokine IL-26 in intestinal inflammation Gut, September 1, 2009; 58(9): 1207 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Brand Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease Gut, August 1, 2009; 58(8): 1152 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Li, X. Liu, Y. Zhou, and S. B. Su Interferon-{lambda}s: the modulators of antivirus, antitumor, and immune responses J. Leukoc. Biol., July 1, 2009; 86(1): 23 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hou, X. Wang, L. Ye, L. Zhou, Z.-Q. Yang, E. Riedel, and W.-Z. Ho Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of Macrophages J. Virol., April 15, 2009; 83(8): 3834 - 3842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wolk, K. Witte, E. Witte, S. Proesch, G. Schulze-Tanzil, K. Nasilowska, J. Thilo, K. Asadullah, W. Sterry, H.-D. Volk, et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes J. Leukoc. Biol., May 1, 2008; 83(5): 1181 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. B. Bergstrom, J. A. Guttman, M. Rumi, C. Ma, S. Bouzari, M. A. Khan, D. L. Gibson, A. W. Vogl, and B. A. Vallance Modulation of Intestinal Goblet Cell Function during Infection by an Attaching and Effacing Bacterial Pathogen Infect. Immun., February 1, 2008; 76(2): 796 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dambacher, F. Beigel, J. Seiderer, D. Haller, B. Goke, C. J Auernhammer, and S. Brand Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease Gut, September 1, 2007; 56(9): 1257 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhou, O. J. Hamming, N. Ank, S. R. Paludan, A. L. Nielsen, and R. Hartmann Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein Kinases J. Virol., July 15, 2007; 81(14): 7749 - 7758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zitzmann, S. Brand, E. N. De Toni, S. Baehs, B. Goke, J. Meinecke, G. Spottl, H. H.H.D. Meyer, and C. J. Auernhammer SOCS1 Silencing Enhances Antitumor Activity of Type I IFNs by Regulating Apoptosis in Neuroendocrine Tumor Cells Cancer Res., May 15, 2007; 67(10): 5025 - 5032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brand, J. Dambacher, F. Beigel, K. Zitzmann, M. H. J. Heeg, T. S. Weiss, T. Prufer, T. Olszak, C. J. Steib, M. Storr, et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1019 - G1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ank, H. West, C. Bartholdy, K. Eriksson, A. R. Thomsen, and S. R. Paludan Lambda Interferon (IFN-{lambda}), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo J. Virol., May 1, 2006; 80(9): 4501 - 4509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brand, F. Beigel, T. Olszak, K. Zitzmann, S. T. Eichhorst, J.-M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G827 - G838. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
